Cargando…
Gut bacteria-derived 5-hydroxyindole is a potent stimulant of intestinal motility via its action on L-type calcium channels
Microbial conversion of dietary or drug substrates into small bioactive molecules represents a regulatory mechanism by which the gut microbiota alters intestinal physiology. Here, we show that a wide variety of gut bacteria can metabolize the dietary supplement and antidepressant 5-hydroxytryptophan...
Autores principales: | Waclawiková, Barbora, Bullock, Amber, Schwalbe, Markus, Aranzamendi, Carmen, Nelemans, Sieger A., van Dijk, Gertjan, El Aidy, Sahar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857600/ https://www.ncbi.nlm.nih.gov/pubmed/33481771 http://dx.doi.org/10.1371/journal.pbio.3001070 |
Ejemplares similares
-
Potential binding modes of the gut bacterial metabolite, 5-hydroxyindole, to the intestinal L-type calcium channels and its impact on the microbiota in rats
por: Waclawiková, Barbora, et al.
Publicado: (2022) -
Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies
por: Waclawiková, Barbora, et al.
Publicado: (2022) -
Parkinson’s Disease Medication Alters Small Intestinal Motility and Microbiota Composition in Healthy Rats
por: van Kessel, Sebastiaan P., et al.
Publicado: (2022) -
Role of Microbiota and Tryptophan Metabolites in the Remote Effect of Intestinal Inflammation on Brain and Depression
por: Waclawiková, Barbora, et al.
Publicado: (2018) -
Indole and 7‐hydroxyindole diminish Pseudomonas aeruginosa virulence
por: Lee, Jintae, et al.
Publicado: (2009)